Dose-Painting Linear Accelerator Radiosurgery of Glomus Jugulare With Dosimetric Comparison to Gamma Knife.

Autor:	Valderrama A; Radiation Oncology, University of Miami Sylvester Comprehensive Cancer Center, Miami, USA., Di L; Neurological Surgery, University of Miami Miller School of Medicine, Miami, USA., Bossart E; Radiation Oncology, University of Miami Sylvester Comprehensive Cancer Center, Miami, USA., Eshraghi AA; Otolaryngology, University of Miami Miller School of Medicine, Miami, USA., Mellon EA; Radiation Oncology, University of Miami Sylvester Comprehensive Cancer Center, Miami, USA.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2024 Feb 27; Vol. 16 (2), pp. e55070. Date of Electronic Publication: 2024 Feb 27 (Print Publication: 2024).
DOI:	10.7759/cureus.55070
Abstrakt:	Objectives In this study, we outline our rationale for delivering a dose of ≥15 Gy in stereotactic radiosurgery (SRS) of glomus jugulare tumor (GJT) while ensuring the avoidance of complications associated with doses >13 Gy to the facial nerve. To avoid such complications, we initially utilized the Gamma Knife Perfexion (GK) system (Elekta Instrument AB, Stockholm, Sweden) at our institution but encountered challenges related to lengthy treatment times and difficulty in sculpting doses to minimize doses to spare the facial nerve. As a potential solution, we propose the use of HyperArc (Varian Medical Systems, Palo Alto, CA), a newly developed automated delivery platform for linear accelerator (LINAC)-based SRS. HyperArc offers the potential for faster treatment and more complex shaping of the radiotherapy dose with multiple arcs and multi-leaf collimators. Methods We retrospectively reviewed nine cases of patients with GJT treated with HyperArc. Patients' demographic and treatment data were collected. Additionally, simulated GK treatment plans were created and compared with HyperArc plans to assess time savings, PTV coverage, and plan quality. Results One male and eight female patients, with a mean age of 63.9 years, were included. Treatments were delivered on average in 29 minutes, achieving 95-100% of the tumor while limiting the facial nerve to <13 Gy. Treatments replanned using our GK system could achieve only 92-99% tumor coverage while respecting facial nerve constraints, with average treatment times of 180 minutes. Comparable plan quality parameters were attained with both modalities. Conclusions The HyperArc system provides a qualitatively satisfactory and rapid treatment delivery of a highly sculpted radiotherapy dose to maximize tumor coverage and minimize facial nerve complications. Competing Interests: The authors have declared financial relationships, which are detailed in the next section. (Copyright © 2024, Valderrama et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu